Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_assertion type Assertion NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_head.
- NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_assertion description "[Angiotensin-converting enzyme (ACE) inhibitors are first-line therapy for the treatment of hypertension, congestive heart failure, and diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_provenance.
- NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_assertion evidence source_evidence_literature NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_provenance.
- NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_assertion SIO_000772 23730990 NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_provenance.
- NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_assertion wasDerivedFrom befree-2016 NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_provenance.
- NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_assertion wasGeneratedBy ECO_0000203 NP1082971.RAYLuaufPpRSPqBfibq7GIA38B2xhpGv7ajd_esdF_W6E130_provenance.